The treatment of hypertension in pregnancy

References

• Bauer J. H., Brooks C. S. The long term effect of propranolol therapy on renal function. Am. J. Med. 1979; 66: 405–4101. Bauer J. H., Brooks C. S. The long term effect of propranolol therapy on renal function. Am. J. Med. 1979; 66: 405–410
   PubMed Web of Science ®Google Scholar
• Butler N. R., Bonham D. G. “Perinatal Mortality. The Final Report of the 1958 British Perinatal Mortality Survey”. Livingstone, Edinburgh 19632. Butler N. R., Bonham D. G. “Perinatal Mortality. The Final Report of the 1958 British Perinatal Mortality Survey”. Livingstone, Edinburgh 1963
   Google Scholar
• Chamberlain G. V. P., Lewis P. J., De Swiet M., Bulpitt C. J. How obstetricians manage hypertension in pregnancy. Br. Med. J. 1978; 1: 626–6293. Chamberlain G. V. P., Lewis P. J., De Swiet M., Bulpitt C. J. How obstetricians manage hypertension in pregnancy. Br. Med. J. 1978; 1: 626–629
   PubMed Web of Science ®Google Scholar
• Chamberlain G., Philip E., Howlett B., Masters K. “British Births”. Heinemann, London 1970; Vol. 24. Chamberlain G., Philip E., Howlett B., Masters K. “British Births”. Heinemann, London 1970; Vol. 2
   Google Scholar
• Cockburn J., Moar V. A., Ounsted M., Redman C. W. G. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982; 1: 647–6495. Cockburn J., Moar V. A., Ounsted M., Redman C. W. G. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982; 1: 647–649
   PubMed Web of Science ®Google Scholar
• Gallery E. D. M., Saunders D. M., Hunyor S. N., Gyory A. Z. Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. Br. Med. J. 1979; 1: 1591–15946. Gallery E. D. M., Saunders D. M., Hunyor S. N., Gyory A. Z. Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. Br. Med. J. 1979; 1: 1591–1594
   PubMed Web of Science ®Google Scholar
• Goldby F. S., Beilin L. J. Relationship between arterial pressure and the permeability of arterioles to carbon particles in acute hypertension in the rat. Cardiovasc. Res. 1972; 6: 384–3907. Goldby F. S., Beilin L. J. Relationship between arterial pressure and the permeability of arterioles to carbon particles in acute hypertension in the rat. Cardiovasc. Res. 1972; 6: 384–390
   PubMed Web of Science ®Google Scholar
• Goldby F. S., Beilin L. J. How an acute rise in arterial pressure damages arterioles. Electronmicroscopic changes during angiotensin infusion. Cardiovasc. Res. 1972; 6: 569–5848. Goldby F. S., Beilin L. J. How an acute rise in arterial pressure damages arterioles. Electronmicroscopic changes during angiotensin infusion. Cardiovasc. Res. 1972; 6: 569–584
   PubMed Web of Science ®Google Scholar
• Lamming G. D., Broughton-Pipkin E, Symonds E. M. Comparison of the alpha and beta blocking drug, labetalol, and methyldopa in the treatment of moderate, and severe pregnancy-induced hypertension. Clin. Exper. Hypertension 1980; 2: 865–8959. Lamming G. D., Broughton-Pipkin E, Symonds E. M. Comparison of the alpha and beta blocking drug, labetalol, and methyldopa in the treatment of moderate, and severe pregnancy-induced hypertension. Clin. Exper. Hypertension 1980; 2: 865–895
   PubMed Web of Science ®Google Scholar
• Leather H. M., Humphreys D. M., Baker P., Chadd M. A. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet 1968; 2: 488–49010. Leather H. M., Humphreys D. M., Baker P., Chadd M. A. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet 1968; 2: 488–490
   PubMed Web of Science ®Google Scholar
• Michael C. A. Use of labetalol in the treatment of severe hypertension during pregnancy. Br. J. Clin. Pharmacol. 1979; 8: 211S–215S11. Michael C. A. Use of labetalol in the treatment of severe hypertension during pregnancy. Br. J. Clin. Pharmacol. 1979; 8: 211S–215S
   PubMed Web of Science ®Google Scholar
• Mutch L. M. M., Moar V. A., Ounsted M. K., Redman C. W. G. Hypertension during pregnancy, with and without specific hypotensive treatment. II. The growth and development in the first year of life. Early Hum. Dev. 1977; 1: 59–6712. Mutch L. M. M., Moar V. A., Ounsted M. K., Redman C. W. G. Hypertension during pregnancy, with and without specific hypotensive treatment. II. The growth and development in the first year of life. Early Hum. Dev. 1977; 1: 59–67
   PubMed Web of Science ®Google Scholar
• Ounsted M., Moar V., Redman C. W. G. Infant growth and development following treatment of maternal hypertension. Lancet 1980; 1: 70513. Ounsted M., Moar V., Redman C. W. G. Infant growth and development following treatment of maternal hypertension. Lancet 1980; 1: 705
   PubMed Web of Science ®Google Scholar
• Page E. W., Christianson R. The impact of mean arterial pressure in the middle trimester upon outcome of pregnancy. Am. J. Obstet. Gynecol. 1976; 125: 740–74614. Page E. W., Christianson R. The impact of mean arterial pressure in the middle trimester upon outcome of pregnancy. Am. J. Obstet. Gynecol. 1976; 125: 740–746
   PubMed Web of Science ®Google Scholar
• Redman C. W. G. Treatment of hypertension in pregnancy. Kidney Int. 1980; 18: 267–27815. Redman C. W. G. Treatment of hypertension in pregnancy. Kidney Int. 1980; 18: 267–278
   PubMed Web of Science ®Google Scholar
• Redman C. W. G., Beilin L. J., Bonnar J., Ounsted M. K. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976; 2: 753–75616. Redman C. W. G., Beilin L. J., Bonnar J., Ounsted M. K. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976; 2: 753–756
   PubMed Web of Science ®Google Scholar
• Rubin P. C. Beta-blockers in pregnancy. N. Engl. J. Med. 1981; 305: 1323–132617. Rubin P. C. Beta-blockers in pregnancy. N. Engl. J. Med. 1981; 305: 1323–1326
   PubMed Web of Science ®Google Scholar
• Report on confidential enquiries into maternal deaths in England and Wales 1973–1975. H.M.S.O., London 197918. Report on confidential enquiries into maternal deaths in England and Wales 1973–1975. H.M.S.O., London 1979
   Google Scholar
• Silverstone A., Trudinger B. J., Lewis P. J., Bulpitt C. J. Maternal hypertension and intrauterine fetal death in mid pregnancy. Br. J. Obstet. Gynaecol. 1980; 87: 457–46119. Silverstone A., Trudinger B. J., Lewis P. J., Bulpitt C. J. Maternal hypertension and intrauterine fetal death in mid pregnancy. Br. J. Obstet. Gynaecol. 1980; 87: 457–461
   PubMedGoogle Scholar
• Walker J. J., Crooks A., Erwin L., Calder A. A. Labetalol in pregnancy-induced hypertension: fetal and maternal effects. “The Investigation of Labetalol in the Management of Hypertension in Pregnancy”, A. Riley, E. M. Symonds. Excerpta Medica, Amsterdam 1982, ICS No. 59120. Walker J. J., Crooks A., Erwin L., Calder A. A. Labetalol in pregnancy-induced hypertension: fetal and maternal effects. “The Investigation of Labetalol in the Management of Hypertension in Pregnancy”, A. Riley, E. M. Symonds. Excerpta Medica, Amsterdam 1982, ICS No. 591
   Google Scholar
• Walters W. A. W. The effects of sustained maternal hypertension on fetal growth and survival. Lancet. 1966; 2: 1214–121721. Walters W. A. W. The effects of sustained maternal hypertension on fetal growth and survival. Lancet. 1966; 2: 1214–1217
   PubMed Web of Science ®Google Scholar